Growth Metrics

LifeStance Health (LFST) Cost of Revenue (2020 - 2024)

LifeStance Health (LFST) has disclosed Cost of Revenue for 5 consecutive years, with $212.3 million as the latest value for Q3 2024.

  • Quarterly Cost of Revenue rose 13.72% to $212.3 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $829.8 million through Sep 2024, up 14.78% year-over-year, with the annual reading at $753.6 million for FY2023, 21.05% up from the prior year.
  • Cost of Revenue for Q3 2024 was $212.3 million at LifeStance Health, down from $214.5 million in the prior quarter.
  • The five-year high for Cost of Revenue was $214.5 million in Q2 2024, with the low at $31.3 million in Q2 2020.
  • Average Cost of Revenue over 5 years is $151.5 million, with a median of $157.3 million recorded in 2022.
  • The sharpest move saw Cost of Revenue soared 249.61% in 2021, then grew 12.42% in 2024.
  • Over 5 years, Cost of Revenue stood at $68.8 million in 2020, then soared by 97.17% to $135.7 million in 2021, then grew by 22.78% to $166.7 million in 2022, then increased by 18.37% to $197.3 million in 2023, then increased by 7.6% to $212.3 million in 2024.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $212.3 million, $214.5 million, and $205.7 million for Q3 2024, Q2 2024, and Q1 2024 respectively.